Propranolol for infantile hemangioma: An evaluation of its efficacy and safety in Iranian infants
Background: Propranolol has been recently indicated to inhibit the rapid growth and involution of infantile hemangioma. In the present study, we investigated the efficacy and safety of propranolol in Iranian infants. Methods: A total of 30 infants with indications for medical intervention, such as l...
Saved in:
Main Authors: | Fatemeh Livani (Author), Pouran Layegh (Author), Behzad Alizadeh (Author), Mohammad Abbasi Tashnizi (Author), Maryam Amin Moghaddam (Author), Ali Taherian (Author) |
---|---|
Format: | Book |
Published: |
Mashhad University of Medical Sciences,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011) -
Propranolol in the Treatment of Infantile Hemangiomas
by: Tan X, et al.
Published: (2021) -
Propranolol for treatment of infantile hemangiomas
by: Juliana Nakano de Melo, et al.
Published: (2013) -
Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study
by: Eiko Nagata, et al.
Published: (2022) -
Infantile hemangioma treated with systemic propranolol
by: Rashmi Samir Mahajan, et al.
Published: (2021)